Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the history list.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the earlier funding-lapse notice (v3.4.1).SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and color-coded legends explaining additions (green) and deletions (red). Updated the revision tag from v3.3.4 to v3.4.0 and added No FEAR Act Data.SummaryDifference0.7%

- Check62 days agoChange DetectedMinor revision history updates: v3.3.4 added and v3.3.3 removed; these do not affect study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page history shows a new 'Revision: v3.3.3' entry, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items have been removed. These are minor site-wide updates to footer/metadata and do not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.